180 related articles for article (PubMed ID: 18071296)
1. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.
León H; Baczkó I; Sawicki G; Light PE; Schulz R
Br J Pharmacol; 2008 Feb; 153(4):676-83. PubMed ID: 18071296
[TBL] [Abstract][Full Text] [Related]
2. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.
Wang W; Sawicki G; Schulz R
Cardiovasc Res; 2002 Jan; 53(1):165-74. PubMed ID: 11744025
[TBL] [Abstract][Full Text] [Related]
3. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction.
Polewicz D; Cadete VJ; Doroszko A; Hunter BE; Sawicka J; Szczesna-Cordary D; Light PE; Sawicki G
J Cell Mol Med; 2011 May; 15(5):1136-47. PubMed ID: 20518849
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
Lalu MM; Gao CQ; Schulz R
Mol Cell Biochem; 2003 Sep; 251(1-2):61-6. PubMed ID: 14575305
[TBL] [Abstract][Full Text] [Related]
5. Peroxynitrite-Induced Intracellular Ca2+ Depression in Cardiac Myocytes: Role of Sarco/Endoplasmic Reticulum Ca2+ Pump.
Flores-Tamez V; Escalante B; Rios A
Folia Biol (Praha); 2019; 65(5-6):237-245. PubMed ID: 32362307
[TBL] [Abstract][Full Text] [Related]
6. Peroxynitrite and myocardial contractility: in vivo versus in vitro effects.
Katori T; Donzelli S; Tocchetti CG; Miranda KM; Cormaci G; Thomas DD; Ketner EA; Lee MJ; Mancardi D; Wink DA; Kass DA; Paolocci N
Free Radic Biol Med; 2006 Nov; 41(10):1606-18. PubMed ID: 17045928
[TBL] [Abstract][Full Text] [Related]
7. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Bencsik P; Kupai K; Giricz Z; Görbe A; Pipis J; Murlasits Z; Kocsis GF; Varga-Orvos Z; Puskás LG; Csonka C; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H512-8. PubMed ID: 20543091
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.
Moshal KS; Tipparaju SM; Vacek TP; Kumar M; Singh M; Frank IE; Patibandla PK; Tyagi N; Rai J; Metreveli N; Rodriguez WE; Tseng MT; Tyagi SC
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H890-7. PubMed ID: 18567713
[TBL] [Abstract][Full Text] [Related]
9. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.
Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Lee TYT; Mahmud Z; Schulz R
Basic Res Cardiol; 2019 Sep; 114(6):42. PubMed ID: 31506724
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes.
Esberg LB; Ren J
Diabetologia; 2003 Oct; 46(10):1419-27. PubMed ID: 12898015
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide causes cardiac dysfunction independent from its effects on matrix metalloproteinase-2 activation.
León H; Bautista-López N; Sawicka J; Schulz R
Can J Physiol Pharmacol; 2007; 85(3-4):341-8. PubMed ID: 17612643
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2.
Castro MM; Fuah J; Ali M; Sung M; Schulz J; Kondo MY; Fan X; Holt A; Schulz R
Biochem Pharmacol; 2013 Aug; 86(4):469-75. PubMed ID: 23774623
[TBL] [Abstract][Full Text] [Related]
13. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.
Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Sergi C; Keschrumrus V; Churko JM; Granzier H; Schulz R
Cardiovasc Res; 2021 Jan; 117(1):188-200. PubMed ID: 31995179
[TBL] [Abstract][Full Text] [Related]
14. Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury.
Bil-Lula I; Lin HB; Biały D; Wawrzyńska M; Diebel L; Sawicka J; Woźniak M; Sawicki G
J Cell Mol Med; 2016 Jun; 20(6):1086-94. PubMed ID: 26992120
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
[TBL] [Abstract][Full Text] [Related]
16. Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes.
Soloviev A; Stefanov A; Parshikov A; Khromov A; Moibenko A; Kvotchina L; Balavoine G; Geletii Y
Cardiovasc Toxicol; 2002; 2(2):129-39. PubMed ID: 12271156
[TBL] [Abstract][Full Text] [Related]
17. Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.
Roczkowsky A; Chan BYH; Lee TYT; Mahmud Z; Hartley B; Julien O; Armanious G; Young HS; Schulz R
Cardiovasc Res; 2020 Apr; 116(5):1021-1031. PubMed ID: 31373602
[TBL] [Abstract][Full Text] [Related]
18. Role of Ca2+-dependent metalloprotease-2 in stimulating Ca2+ ATPase activity under peroxynitrite treatment in bovine pulmonary artery smooth muscle membrane.
Chakraborti T; Das S; Mandal M; Mandal A; Chakraborti S
IUBMB Life; 2002 Mar; 53(3):167-73. PubMed ID: 12102173
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.
Gao CQ; Sawicki G; Suarez-Pinzon WL; Csont T; Wozniak M; Ferdinandy P; Schulz R
Cardiovasc Res; 2003 Feb; 57(2):426-33. PubMed ID: 12566115
[TBL] [Abstract][Full Text] [Related]
20. Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes.
Yu XW; Liu MY; Kennedy RH; Liu SJ
J Physiol; 2005 Jul; 566(Pt 2):341-53. PubMed ID: 15878941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
